# Aktis Oncology, Inc. (AKTS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Aktis Oncology, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AKTS/mda/fy2025/): filed 2026-03-30; accession 0001193125-26-131748 (https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm); latest 10-K

Back to /company/AKTS/